Liquid Chromatography–mass Spectrometric Assay for the Quantitation in Human Plasma of ABT-888, an Orally Available, Small Molecule Inhibitor of Poly(ADP-Ribose) Polymerase

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences - Netherlands
doi 10.1016/j.jchromb.2008.07.032
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Liquid Chromatographic Determination of NSC 737664 (ABT-888: An Inhibitor of Poly(ADP-Ribose) Polymerase (PARP)) in Plasma and Urine in a Phase 0 Clinical Trial

Journal of Liquid Chromatography and Related Technologies
BiochemistryClinical BiochemistryAnalytical ChemistryPharmaceutical Science
2008English

Liquid Chromatography–mass Spectrometric Assay for Quantitation of the Short-Chain Fatty Acid, 2,2-Dimethylbutyrate (NSC 741804), in Rat Plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
BiochemistryClinical BiochemistryAnalytical ChemistryCell BiologyMedicine
2008English

Liquid Chromatography–tandem Mass Spectrometric Assay for the Quantitation in Human Plasma of the Novel Indenoisoquinoline Topoisomerase I Inhibitors, NSC 743400 and NSC 725776

Journal of Pharmaceutical and Biomedical Analysis
Clinical BiochemistryDrug DiscoveryAnalytical ChemistrySpectroscopyPharmaceutical Science
2010English

Poly (ADP-ribose) Polymerase Inhibitor, an Effective Radiosensitizer in Lung and Pancreatic Cancers

Oncotarget
Oncology
2017English

Vasoactivity of AG014699, a Clinically Active Small Molecule Inhibitor of Poly(ADP-Ribose) Polymerase: A Contributory Factor to Chemopotentiation in Vivo?

Clinical Cancer Research
Cancer ResearchOncology
2009English

Proteomic Investigation of Phosphorylation Sites in Poly(ADP-Ribose) Polymerase-1 and Poly(ADP-Ribose) Glycohydrolase

Journal of Proteome Research
BiochemistryChemistry
2009English

Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes

Cancers
Cancer ResearchOncology
2019English

Targeting Poly(ADP-Ribose) Polymerase Activity for Cancer Therapy

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2010English

Characterization of Absorption, Metabolism, and Elimination of Niraparib, an Investigational Poly (ADP-Ribose) Polymerase Inhibitor, in Cancer Patients

Clinical Therapeutics
Pharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy